Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Eric Patzer Insider Profile
4 Followers
Eric Patzer, Director at Aridis Pharmaceuticals, holds 884.60K shares in Aridis Pharmaceuticals (Ticker: ARDS). Most recently, Eric Patzer Bought $714,286 shares of Aridis Pharmaceuticals on Jun 28, 2024 for an estimated value of 50.00K.
Eric Patzer Aridis Pharmaceuticals (ARDS)Director
Aridis Pharmaceuticals (ARDS)
Director
Not Ranked
Ranked #44,406 out of 100,370 Corporate Insiders
Eric Patzer has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Director
Roles that Eric Patzer holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jul 27, 2021 - Jul 27, 2022
Return:-71.40%
The most profitable trade made by Eric Patzer
Eric Patzer's Trading History
List of latest transactions for each holding click on a transaction to see Eric Patzer's performance on stock
You May Also Like
Eric Patzer insider profile FAQ
What is the percentage of profitable transactions made by Eric Patzer?
The percentage of profitable transactions made by Eric Patzer is ―.
What is the average return per transaction made by Eric Patzer?
The average return per transaction made by Eric Patzer is ―.
What stocks does Eric Patzer hold?
Eric Patzer holds: ARDS stocks.
What was Eric Patzer’s latest transaction?
Eric Patzer latest transaction was an Informative Buy of $50.00K.
What was Eric Patzer's most profitable transaction?
Eric Patzer’s most profitable transaction was an Informative Buy of ARDS stock on July 27, 2021. The return on the trade was -71.40%.
What is Eric Patzer's role in Aridis Pharmaceuticals?
Eric Patzer's role in Aridis Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.